Published in Hepatogastroenterology on January 08, 2001
Serum Levels of IL-10 and IL-17A in Occult HBV-Infected South-East Iranian Patients. Hepat Mon (2010) 1.34
Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol (2007) 1.27
Infected CD8α- dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection. Proc Natl Acad Sci U S A (2012) 1.00
Relationship between TNF-<alpha> gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis. PLoS One (2011) 0.91
Monocytes from chronic HBV patients react in vitro to HBsAg and TLR by producing cytokines irrespective of stage of disease. PLoS One (2014) 0.88
Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice. World J Gastroenterol (2001) 0.87
Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol (2004) 0.86
Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestry. PLoS One (2011) 0.84
Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population. Indian J Med Res (2014) 0.82
Gender specific medicine in liver diseases: a point of view. World J Gastroenterol (2014) 0.79
He Jie Tang in the treatment of chronic hepatitis B patients. World J Gastroenterol (2005) 0.78
Circulating cytokines and histological liver damage in chronic hepatitis B infection. Hepat Res Treat (2013) 0.78
Association of TNF-α Promoter Polymorphism with HBV Associated Disease Outcome Among HBV Infected Patients from Orissa, Southern Part of East India. J Clin Exp Hepatol (2014) 0.77
Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 2.49
Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B. Gut (2006) 1.95
Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res (1999) 1.62
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis. J Viral Hepat (2012) 1.21
Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat (2004) 1.19
Cytotoxic CD4 T cells in viral hepatitis. J Viral Hepat (2006) 1.12
Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. J Viral Hepat (2008) 1.11
YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine. J Viral Hepat (2003) 1.08
Successful medical treatment of an epithelioid hemangioendothelioma of liver. Oncology (1997) 1.08
Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology (1989) 1.06
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med (1995) 1.04
Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch Virol (2004) 1.03
Blood pressure nomograms for children and adolescents in Turkey. Pediatr Nephrol (1999) 1.02
Diet and stomach cancer incidence. A case-control study in Turkey. Cancer (1990) 0.98
Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B. J Viral Hepat (2005) 0.95
Hypoxia-induced necrotizing enterocolitis in the immature rat: the role of lipid peroxidation and management by vitamin E. J Pediatr Surg (1995) 0.95
Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci (2001) 0.95
Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection. Hepatogastroenterology (2000) 0.95
The effectiveness of omeprazole versus lansoprazole along with amoxicillin and clarithromycin in Turkish population with duodenal ulcer. Minerva Gastroenterol Dietol (2003) 0.94
A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene. J Virol Methods (1996) 0.90
A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients. J Viral Hepat (2009) 0.89
Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting. J Viral Hepat (2014) 0.88
The diagnostic value of on-site cytopathological evaluation and cell block preparation in fine-needle aspiration cytology of liver masses. Cytopathology (2006) 0.87
Multimodality demonstration of primary splenic angiosarcoma. J Clin Ultrasound (1999) 0.87
Hepatic osteodystrophy: a review. Hepatogastroenterology (1997) 0.87
Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels. J Clin Virol (2001) 0.86
Oxidative enzymes of polymorphonuclear leucocytes and plasma fibrinogen, ceruloplasmin, and copper levels in Behçet's disease. Clin Biochem (1994) 0.84
Protein oxidation status in patients with ankylosing spondylitis. Rheumatology (Oxford) (2004) 0.84
Increased advanced oxidation protein products in Behçet's disease: a new activity marker? Br J Dermatol (2004) 0.83
Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients. J Viral Hepat (2011) 0.82
Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats. Hum Exp Toxicol (1999) 0.81
Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR alleles. Tissue Antigens (2006) 0.81
Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci (1988) 0.81
Dilation therapy of upper esophageal webs in two cases of Plummer-Vinson syndrome. Endoscopy (1996) 0.81
Circulating IL-2 and IL-10 in chronic active hepatitis C with respect to the response to IFN treatment. Infection (2000) 0.81
Single dose ciprofloxacin in cholera. Eur J Emerg Med (1997) 0.81
Opioid receptor ligands in human hepatic encephalopathy. J Hepatol (1998) 0.81
Effect of postnecrotic and alcoholic hepatic cirrhosis on development of benign prostatic hyperplasia. Prostate (1998) 0.81
Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection. J Viral Hepat (2011) 0.79
Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines. Arch Virol (2007) 0.79
Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta. J Viral Hepat (2013) 0.79
Comparison of two regimens for ciprofloxacin treatment of enteric infections. Eur J Clin Microbiol Infect Dis (1997) 0.79
Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma. Med Oncol (2000) 0.79
Polymorphism of precore region of hepatitis B virus DNA among patients with chronic HBV infection in Turkey. Infection (2000) 0.79
Is fatigue associated with cholestasis mediated by altered central neurotransmission? Hepatology (1997) 0.78
Effect of nitric oxide synthase inhibitor on experimentally induced burn wounds. J Trauma (2000) 0.78
Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Behçet's disease. Clin Rheumatol (2008) 0.77
Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection. J Eur Acad Dermatol Venereol (2006) 0.77
Simplified retroperfusion system preserves the myocardial function during acute coronary artery occlusion. Thorac Cardiovasc Surg (1998) 0.77
Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin. Digestion (2007) 0.77
Changes in platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in lithium-treated bipolar patients. Psychiatry Res (1995) 0.77
The effects of dialyzer reuse on plasma antioxidative mechanisms in patients on regular hemodialysis treatment. Free Radic Biol Med (1996) 0.77
Influence of viral load and alanine aminotransferase on viral genetic heterogeneity in patients with chronic hepatitis C virus infection. Intervirology (2000) 0.76
The European Organization for Research and Treatment of Cancer core quality of life questionnaire (QLQ-C30 version 3.0 Turkish) in cancer patients receiving palliative radiotherapy. Eur J Cancer Care (Engl) (2007) 0.76
Myocardial hemodynamic and metabolic changes during abdominal insufflation with carbon dioxide. Eur Surg Res (1998) 0.75
The effects of montelukast against amikacin-induced acute renal damage. Eur Rev Med Pharmacol Sci (2012) 0.75
Treatment by functional electrical therapy of an unresolved peritoneal leakage in a peritoneal dialysis patient. Perit Dial Int (2012) 0.75
Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. Eur J Clin Invest (2004) 0.75
Combination treatment of hepatic encephalopathy due to thioacetamide-induced fulminant hepatic failure in the rat with benzodiazepine and opioid receptor antagonists. J Hepatol (1999) 0.75
The GABA hypothesis--state of the art. Adv Exp Med Biol (1994) 0.75
Demographical, laboratory and associated findings in patients with perniosis. J Eur Acad Dermatol Venereol (2013) 0.75
[Antibacterial effects of arsenic on pulp necrosis using the plate diffusion method]. Mikrobiyol Bul (1979) 0.75
An ultrastructural study on the presence of various types of crystals in the infertile human testis. Anat Embryol (Berl) (1985) 0.75
Triple-drug regimen for first kidney transplants in developing countries. Transplant Proc (1992) 0.75
Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis. Dig Dis Sci (1997) 0.75
The beneficial effects of aminophylline administration on heparin reversal with protamine. Surg Today (1994) 0.75
Beneficial effects of verapamil in renal transplantation. Transplant Proc (1993) 0.75
Do benzodiazepine ligands contribute to hepatic encephalopathy? Adv Exp Med Biol (1993) 0.75
[Parasite prevalence in schools with different socioeconomic status and evaluation of methods for diagnosing intestinal parasitic diseases]. Mikrobiyol Bul (1990) 0.75
Prevalence of hepatitis delta virus infection in three different areas of Turkey. Prog Clin Biol Res (1987) 0.75
Hereditary pancreatitis: report of a family from Turkey. Acta Paediatr Jpn (1998) 0.75
Flow cytometric measurement of proliferation-associated nuclear antigen P105 and DNA content in immuno-proliferative small intestinal disease (IPSID). J Surg Oncol (1995) 0.75
Beneficial effects of prostacyclin treatment on reperfusion of the myocardium. Cardiovasc Surg (1995) 0.75
Influence of two blood conservation techniques (cardiotomy reservoir versus cell-saver) on biocompatibility of the heparin coated cardiopulmonary bypass circuit during coronary revascularization surgery. J Card Surg (1998) 0.75
Endoscopic papillotomy in a child with a biliocutaneous fistula. Endoscopy (1994) 0.75
Low-versus high-dose corticosteroid therapy in living-related kidney transplantation. Transplant Proc (1993) 0.75
Arachidonic acid metabolites as biocompatibility parameters for cellulosic membranes. Nephrol Dial Transplant (1999) 0.75
The role of endogenous benzodiazepines in hepatic encephalopathy: animal studies. Alcohol Alcohol Suppl (1993) 0.75